The biobanking group takes care of collecting, storing, and managing biological samples for research purposes within the network.

The Diagnostic Procedure Group evaluates and validates diagnostic methods with the aim to harmonize diagnostic procedures and methods across the network.

This multidisciplinary group evaluates leishmaniasis trends in Europe by employing a One Health approach to monitor incidence patterns, circulating strains, emerging hotspots, and shifts in transmission dynamics.

The group is reachable under the email: Epidemiology_LeishMan@live.unibo.it

The topical paromomycin for CL treatment group focuses on the development and implementation of a planned prospective study to evaluate topical paromomycin treatment for cutaneous leishmaniasis within the network.

The treatment recommendation for CL group focuses on compiling and updating best evidence-based, species-specific treatment recommendations for cutaneous and mucosal leishmaniasis.

The VL treatment in immunocompromized group focuses on the treatment of visceral leishmaniasis in immunocompromised patients, analyzing the practices proposed throughout Europe, particularly in the event of relapse, and also concerning secondary prophylaxis.